Dr. Sorush Niknamian. Ph.D in Cellular and Molecular Biology from the University of Cambridge. He is certified with CSci (Chartered Scientist), RSciTech (Registered Science Technician), RSci (Registered Scientist) and Science Council, United Kingdom and Indiana Cancer Consortium (ICC). He has been published 27 books in medical and biological sciences including cancer prevention and treatment. He has published more than 25 research articles in international high impact journals in many fields of medicine. He has been working on cancer treatment, Cause and Prevention working with the Professor Thomas N. Seyfried, Professor Stephanie Seneff, Professor Domonic D’Agostino and Miriam Kalamian. He has hypothesized cancer as an evolutionary metabolic disease (Disorder) and introduced a new protocol in the treatment of cancer. He is a Professional Reviewer at National Institute for Health Research (NIHR), United Kingdom, Editor of the Publishing Research Group, American Society of Clinical Oncology (ASCO), Member of peer review corps at Journal of Clinical Oncology (JCO), JCO Clinical Cancer Informatics, JCO Precision Oncology, Journal of Oncology Practice, Dove Medical Press (Adolescent Health, Medicine and Therapeutics Journal), Dove Medical Press. (Biologics: Targets and Therapy Journal) and Dove Medical Press (Cancer Management and Research) and etc. He is the Guest editor of Nature Medicine Journal and the editorial Board Member of Global Access Publishers (Global Journal of Neurology). He is a nominee of Edison Award 2019.
Research Interest:Breast Cancer, Cancer Biology, Cancer Cell Biology, Cancer Research, HIV/Aids, Lung Cancer, Medical Biochemistry and Metabolomics, Metabolic Medicine, Multiple Sclerosis, Neuroscience, Oncology, Oncology and Carcinogenesis, Prostate Cancer.